Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Prostanoid receptor ligands reported in recent patent literature by Ono

April 25, 2000

Immunomodulators from Gruenenthal affect IL-10 and IL-12 production

April 24, 2000

Antex Biologics makes progress in traveler's diarrhea vaccine

April 18, 2000

Novel copolymer adjuvant enhances flu vaccine efficacy and immunogenicity

April 17, 2000

High antigen response to a single dose of liposomal hepatitis A vaccine

April 14, 2000

BioTransplant initiates phase I/II trial of AlloMune

April 13, 2000

SangCya approved in Germany

April 12, 2000

Wyeth Lederle Vaccines gains expanded access to Corixa's MPL adjuvant

April 10, 2000

Hepatitis B vaccine incorporating new adjuvant requires fewer doses, has enhanced efficacy

April 10, 2000

ImClone Systems reports positive preclinical data from gp75 melanoma vaccine study

April 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.